5HT2A and 5HT2C Receptor Polymorphisms And Predicting Clinical Response to Olanzapine in Schizophrenia

This publication has 12 references indexed in Scilit:

• Pharmacogenetic prediction of clozapine response
  The Lancet, 2000
• Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia
  The Lancet, 1997
• Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine
  Neuroscience Letters, 1996
• Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene
  The Lancet, 1996
• Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia
  Human Genetics, 1996
• Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia
  American Journal of Medical Genetics, 1996
• Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1995
• Identification, Expression, and Pharmacology of a Cys23-Ser23 Substitution in the Human 5-HT2C Receptor Gene (HTR2C)
  Genomics, 1995
• The Comprehensive Assessment of Symptoms and History (CASH)
  Archives of General Psychiatry, 1992
• THE BRIEF PSYCHIATRIC RATING SCALE
  Psychological Reports, 1962